Multimodal Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma -ECF vs. FLOT

被引：0
|
作者：
Schroeder, W. [1 ]
Bruns, C. J. [1 ]
机构：
[1] Univ Klin Koln, Klin Allgemein Viszeral & Tumorchirurg, Kerpener Str 62, D-50937 Cologne, Germany
来源：
CHIRURG | 2019年 / 90卷
关键词：
D O I：
10.1007/s00104-019-0841-4
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
    Perkhofer, Lukas
    Hann, Alexander
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 1656 - 1658
  • [32] Gastric or gastro-oesophageal Junction Adenocarcinoma: FLOT improves overall Survival
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (09): : 1042 - 1042
  • [33] Two-center experience comparing the use of the FLOT4 and CROSS schemes for patients with gastric, esophageal, and gastroesophageal junction adenocarcinoma
    Lopez, Irene Solana
    Abad, David Gutierrez
    Olombrada, Maria Victoria de Torres
    Moreno, Elia Martinez
    Martel, Ignacio Juez
    Nuno, Alicia Hurtado
    de Soignie, Ana Manuela Martin Fernandez
    Luque, Carlos de Zea
    Banos, Nadia Sanchez
    Martin, Fatima Escalona
    Vila, Beatriz Losada
    Gonzalez, Carmen Pantin
    Lajusticia, Laura Rodriguez
    Gimenez, Diego Malon
    Munarriz, Beatriz Jimenez
    Lopez, Roberto Hernandez
    Rodriguez, Julia Calzas
    Martinez, Juan Antonio Guerra
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (05): : 311 - 318
  • [34] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy.
    Liu, Ning
    Liu, Zimin
    Zhou, Yanbing
    Niu, Zhaojian
    Jiang, Haitao
    Zhu, Yingqian
    Wang, Huiyun
    Li, Xiaoxiao
    Song, Shanai
    Liu, Xiaodong
    Li, Zequn
    Zhao, Shufen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
    Li, Hongli
    Deng, Jingyu
    Ge, Shaohua
    Zang, Fenglin
    Zhang, Le
    Ren, Peng
    Wang, Baogui
    Cao, Fuliang
    Deng, Ting
    Liu, Rui
    Ning, Tao
    Yang, Yuchong
    Bai, Ming
    Wang, Xia
    Ji, Zhi
    Duan, Jingjing
    Liu, Yong
    Zhou, Dejun
    Liang, Han
    Ba, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Multimodal management of gastroesophageal junction adenocarcinoma: Which type of neoadjuvant treatment?
    Zandirad, E.
    Teixeira-Farinha, H.
    Demartines, N.
    Schafer, M.
    Mantziari, S.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [37] Preoperative chemotherapy flot vs dox in patients of locally advanced gastric adenocarcinoma
    Uthayakumar, P. D.
    Das Majumdar, S. K.
    Barik, S. K.
    Das, D. K.
    Parida, D. K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1472 - S1472
  • [38] Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction
    Hosoda K.
    Yamashita K.
    Katada N.
    Watanabe M.
    General Thoracic and Cardiovascular Surgery, 2015, 63 (10) : 549 - 556
  • [39] Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction
    Wilke, H
    Fink, U
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07): : 509 - 510
  • [40] Pathologic risk factors of adenocarcinoma of the gastric cardia and gastroesophageal junction
    Carneiro, Fatima
    Chaves, Paula
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 15 (04) : 697 - +
12345